Beryl Drugs Limited (BOM:524606)

India · Delayed Price · Currency is INR

21.72

-0.28 (-1.27%)

At close: Jul 28, 2026

4.42% (1Y)

Market Cap	110.16M +4.4%
Revenue (ttm)	188.20M -11.0%
Net Income	4.25M -26.6%
EPS	0.84 -26.3%
Shares Out	5.07M
PE Ratio	25.86
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	980
Open	22.00
Previous Close	22.00
Day's Range	21.01 - 22.00
52-Week Range	15.92 - 30.00
Beta	-0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Beryl Drugs

Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India. [Read more]

Industry Pharmaceutical Preparations

Founded 1993

Country India

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524606

Full Company Profile

Financial Performance

In fiscal year 2026, Beryl Drugs's revenue was 188.20 million, a decrease of -11.00% compared to the previous year's 211.46 million. Earnings were 4.25 million, a decrease of -26.61%.

Financial Statements